Based in Irvine, California, Lumitron Technologies, Inc. was established to develop and commercialize unique laser technology x-ray systems that enable revolutionary new capabilities for high‐fidelity imaging, ultra‐low dose imaging and hyper‐precision radiotherapy.
Location: United States, California, Irvine
Investors 3
Mentions in press and media 5
| Date | Title | Description |
| 25.06.2026 | HANCOCK PROSPECTING BACKS LUMITRON TO ADVANCE WORLD-FIRST MINING, IMAGING AND CANCER THERAPY TECHNOLOGY | Lumitron Technologies Hancock Prospecting Australian-backed investment to support global commercial scale-up of HyperVIEW™ across healthcare and mining industrial applications Lumitron represents the first fundamental change in clinical rad... |
| 14.02.2025 | Lumitron’s HyperVIEW is set to increase accuracy of mammography | Artist rendering of the Lumitron HyperVIEW X-Ray machine Recent study concludes Lumitron’s laser-Compton X-ray source can improve tumor detection by more than 3000% relative to today’s standards. Lumitron’s HyperVIEW laser-Compton X-ray sou... |
| 04.02.2025 | FDA grants 'Breakthrough Device' designation to Lumitron’s HyperVIEWTM cancer detection X-Ray System | Lumitron X-Ray HyperVIEW Breakthrough status announced on World Cancer Day (Feb. 4) This listing on FDA’s Breakthrough Device Program will enable Lumitron’s HyperVIEW X-Ray system to accelerate through the approval process to bring this rev... |
| 07.01.2025 | Lumitron Technologies, Inc. achieves breakthrough that fundamentally changes the way cancer can be detected and treated | Lumitron X-Ray HyperVIEW Lumitron Technologies has created with its HyperVIEW™ image-guided, radiotherapy platform the world’s first compact VHEE, FLASH-ready source. With Lumitron’s HyperVIEW, one might never remove a breast or prostate ag... |
| - | Lumitron Technologies | “Based in Irvine, California, Lumitron Technologies, Inc. was established to develop and commercialize unique laser technology x-ray systems that enable revolutionary new capabilities for high‐fidelity imaging, ultra‐low dose imaging and hy... |